Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Search Results
7 results
Filters applied: . Clear all
Results are displayed in a computed author sort order.
The Results By Year timeline is not available.
Page 1
Safety, target engagement, and biomarker effects of bosutinib in dementia with Lewy bodies.
Alzheimers Dement (N Y). 2022 Jun 1;8(1):e12296. doi: 10.1002/trc2.12296. eCollection 2022.
Alzheimers Dement (N Y). 2022.
PMID: 35662832
Free PMC article.
Nilotinib Effects in Parkinson's disease and Dementia with Lewy bodies.
Pagan F, Hebron M, Valadez EH, Torres-Yaghi Y, Huang X, Mills RR, Wilmarth BM, Howard H, Dunn C, Carlson A, Lawler A, Rogers SL, Falconer RA, Ahn J, Li Z, Moussa C.
Pagan F, et al. Among authors: wilmarth bm.
J Parkinsons Dis. 2016 Jul 11;6(3):503-17. doi: 10.3233/JPD-160867.
J Parkinsons Dis. 2016.
PMID: 27434297
Free PMC article.
Clinical Trial.
Item in Clipboard
Pharmacokinetics and pharmacodynamics of a single dose Nilotinib in individuals with Parkinson's disease.
Pagan FL, Hebron ML, Wilmarth B, Torres-Yaghi Y, Lawler A, Mundel EE, Yusuf N, Starr NJ, Arellano J, Howard HH, Peyton M, Matar S, Liu X, Fowler AJ, Schwartz SL, Ahn J, Moussa C.
Pagan FL, et al. Among authors: wilmarth b.
Pharmacol Res Perspect. 2019 Mar 12;7(2):e00470. doi: 10.1002/prp2.470. eCollection 2019 Apr.
Pharmacol Res Perspect. 2019.
PMID: 30906562
Free PMC article.
Clinical Trial.
Item in Clipboard
Nilotinib Effects on Safety, Tolerability, and Potential Biomarkers in Parkinson Disease: A Phase 2 Randomized Clinical Trial.
Pagan FL, Hebron ML, Wilmarth B, Torres-Yaghi Y, Lawler A, Mundel EE, Yusuf N, Starr NJ, Anjum M, Arellano J, Howard HH, Shi W, Mulki S, Kurd-Misto T, Matar S, Liu X, Ahn J, Moussa C.
Pagan FL, et al. Among authors: wilmarth b.
JAMA Neurol. 2020 Mar 1;77(3):309-317. doi: 10.1001/jamaneurol.2019.4200.
JAMA Neurol. 2020.
PMID: 31841599
Free PMC article.
Clinical Trial.
Item in Clipboard
Long-Term Safety and Clinical Effects of Nilotinib in Parkinson's Disease.
Pagan FL, Wilmarth B, Torres-Yaghi Y, Hebron ML, Mulki S, Ferrante D, Matar S, Ahn J, Moussa C.
Pagan FL, et al. Among authors: wilmarth b.
Mov Disord. 2021 Mar;36(3):740-749. doi: 10.1002/mds.28389. Epub 2020 Nov 20.
Mov Disord. 2021.
PMID: 33215762
Free PMC article.
Clinical Trial.
Item in Clipboard
CSF MicroRNAs Reveal Impairment of Angiogenesis and Autophagy in Parkinson Disease.
Fowler AJ, Ahn J, Hebron M, Chiu T, Ayoub R, Mulki S, Ressom H, Torres-Yaghi Y, Wilmarth B, Pagan FL, Moussa C.
Fowler AJ, et al. Among authors: wilmarth b.
Neurol Genet. 2021 Nov 12;7(6):e633. doi: 10.1212/NXG.0000000000000633. eCollection 2021 Dec.
Neurol Genet. 2021.
PMID: 34786477
Free PMC article.
Item in Clipboard
Can sex influence the neurocognition of language? Evidence from Parkinson's disease.
Reifegerste J, Estabrooke IV, Russell LE, Veríssimo J, Johari K, Wilmarth B, Pagan FL, Moussa C, Ullman MT.
Reifegerste J, et al. Among authors: wilmarth b.
Neuropsychologia. 2020 Nov;148:107633. doi: 10.1016/j.neuropsychologia.2020.107633. Epub 2020 Sep 22.
Neuropsychologia. 2020.
PMID: 32971096
Free PMC article.
Item in Clipboard
Cite
Cite